MARKET

FBLG

FBLG

Fibrobiologics
NASDAQ
8.90
-0.32
-3.47%
Opening 12:46 05/08 EDT
OPEN
9.01
PREV CLOSE
9.22
HIGH
9.01
LOW
8.74
VOLUME
3.08K
TURNOVER
0
52 WEEK HIGH
55.00
52 WEEK LOW
6.53
MARKET CAP
291.20M
P/E (TTM)
-13.1832
1D
5D
1M
3M
1Y
5Y
FibroBiologics to Present at the BIO International Convention 2024
FibroBiologics, Inc. Will present a corporate update on recent business and clinical developments at the 2024 BIO International Convention, June 3-6, 2024, in San Diego. The company is a clinical-stage biotechnology company with 150+ patents issued and pending.
Barchart · 1d ago
Weekly Report: what happened at FBLG last week (0429-0503)?
Weekly Report · 2d ago
Weekly Report: what happened at FBLG last week (0422-0426)?
Weekly Report · 04/29 13:05
FibroBiologics files to sell 1.8M units
FibroBiologics files to sell 1.8M units Apr. 26, 2024. Each unit consists of one share, and one warrant to buy one share. Fibro biologics filed a prospectus related to the sale of 1.7M units at $11.1 per unit.
Seeking Alpha · 04/26 19:23
FIBROBIOLOGICS FILES FOR OFFERING OF UP TO 1.8 MLN UNITS, EACH CONSISTING OF ONE COMMON SHARE, ONE WARRANT TO PURCHASE ONE COMMON SHARE - SEC FILING
Reuters · 04/26 10:08
Fibrobiologics: Correspondence
Press release · 04/25 15:10
FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
Charles River and FibroBiologics will enter into an anticipated master services agreement. Charles River will conduct feasibility studies on fibroblast-based cell manufacturing processes. The company will be responsible for producing drug products for certain Fibro biologics' clinical trials. This comes ahead of entering into a contract with Charles River.
Benzinga · 04/25 12:02
FIBROBIOLOGICS PLANS TO COLLABORATE WITH CHARLES RIVER TO MANUFACTURE FIBROBLAST-BASED SPHEROIDS
Reuters · 04/25 12:00
More
About FBLG
FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.

Webull offers Fibrobiologics Inc stock information, including NASDAQ: FBLG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBLG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBLG stock methods without spending real money on the virtual paper trading platform.